Fosun medicine: artemisinin preparations exports topped the country - artemisinin, preparation and export - the pharmaceutical industry

Fosun medicine: artemisinin preparations exports topped the country - artemisinin

, preparation and export - the pharmaceutical industry

As the API disorderly competition, many domestic enterprises engaged in Artemisia annua industry is facing a sharp drop in performance, but Fosun Pharmaceutical (600 196) of Artemisia annua is still to maintain stable growth industry. Chinese Medicine & Health Products Import and Export Chamber of Commerce, the latest statistics show that 1-9 months of this year, Fosun's Guilin Pharmaceutical Co., Ltd. product formulations of artemisinin more than exports for the first time Beijing Novartis, ranking first in the country.

Chinese medicine and health products Chamber of Commerce statistics, the first three quarters of the total export of agents of Artemisia annua class finished about 40 million U.S. dollars, exports of the top three companies were Guilin Pharmaceutical, Novartis and Beijing Beijing Holley, but The company did not disclose the specific exports. Previously, Novartis has been ranked the world's top spot in the supply of Artemisia annua for malaria, the World Health Organization (WHO) in annual purchases, according to Novartis approximately 80% of the share.

Fosun interview Yan Xiaohua, vice president, said in addition to Beijing Novartis, Novartis has also set up factories abroad, on the whole, Novartis global supply is still far more than Guilin Pharmaceutical. However, Guilin Pharmaceutical artemisinin production also increased rapidly, more than 12 million last year, growth this year will surely exceed 30%.

It is understood that the sale of artemisinin drugs are mainly from the public market and private markets of two parts, the whole public market account for more than 80% of sales channels, including the World Health Organization's multilateral market procurement and bilateral governments market purchases. Guilin Pharmaceutical's new this year, the amount of artemisinin drugs mainly from the public market and bilateral market purchases increased significantly.

China Import and Export Chamber of Commerce Health Care data, Africa remains the largest market for exports of Artemisia annua drugs, the first three quarters of Africa's exports reached 21.714 million yuan market, up 119.8 percent. Yanxiao Hua said that Africa's annual demand for Artemisia annua drugs up to 10 million copies worldwide for the treatment of malaria within the past few years, the costs are to hundreds of millions of dollars, and eventually the supply will depend on global public organization Fund amount of money.

Drugs for the future market prospects of Artemisia annua, Yan Xiaohua very optimistic. He said that while technically, the plant extract artemisinin is still the most effective way to treat malaria, has not yet developed alternative medicines; the other hand, China has a unique geographical advantage of Artemisia annua grown in Africa cultivation of Artemisia annua have found variations, so the premise of guaranteeing quality, how to organize production and supply of orderly artemisinin as key to sustainable development.

It is understood, as many domestic farmers, enterprises have to Artemisia annua grass planting, artemisinin extraction, preparation and production in the industrial chain, resulting in the development of artemisinin market chaos, this year the market price volatility of artemisinin, by the Supreme 8,000 yuan / kg fell to the lowest 1,300 yuan / kg. In this regard, Yan Xiaohua said that Guilin Pharmaceutical Artemisia annua grass has grown its base to provide raw materials for the company's drug, its rivers and mountains Technology Co., Ltd. specializes in the production of artemisinin, the qualifications of its suppliers also been approved by the World Health Organization, which not only insurance companies to the needs of pharmaceutical production of Artemisia annua, also ensure the quality stability.

Although the domestic price volatility of artemisinin, and the impact on the Guilin Pharmaceutical, Yan Xiaohua is still the current disorderly market competition Artemisia concerned, he called for the early introduction of the relevant provisions of the management and regulate market order. It is reported that artemisinin extracted the country more than 80 companies, many of our competitors are very confusing, this, together with relevant departments of the Ministry of Commerce is currently formulating an "order of artemisinin-based export management approach", while also on Artemisia annua Prime export license management products.

POST COMMENT

Depression Drugs - Is More Than One Really Necessary? Drug Rehab: Lets You Win The Battle Of Life Frequently Asked Questions About Medical Negligence Solicitors Drug Driver Causes and Plant Medicine for IBS MCV and Plant Medicine for Molluscum Contagiosum Plant Medicine is the Best Treatment for Varicose Veins Why people Choose Plant Medicine for Nail Fungus? Laughter is the best medicine Get medical marijuana treatment with Medical Marijuana Card Chemicals And Face Washes Located In Your Local Drug Store Are No Longer The Answer To Acne Know about Medical Billing and Coding Classes Swami ramdev Ayurvedic medicines for blood sugar